Similar articles for PMID: 28893820

Year	Number of Results
2002	1
2004	4
2005	3
2006	1
2007	6
2008	5
2009	3
2010	6
2011	3
2012	1
2013	2
2014	1
2015	12
2016	10
2017	5
2022	0

1

Providing Office-Based Treatment of Opioid Use Disorder.

Wilson CG, Fagan EB. Wilson CG, et al. Ann Fam Med. 2017 Sep;15(5):481. doi: 10.1370/afm.2139. Ann Fam Med. 2017. PMID: 28893820 Free PMC article. No abstract available.

2

Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.

Bhatraju EP, Grossman E, Tofighi B, McNeely J, DiRocco D, Flannery M, Garment A, Goldfeld K, Gourevitch MN, Lee JD. Bhatraju EP, et al. Addict Sci Clin Pract. 2017 Feb 28;12(1):7. doi: 10.1186/s13722-017-0072-2. Addict Sci Clin Pract. 2017. PMID: 28245872 Free PMC article.

3

Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.

LaBelle CT, Han SC, Bergeron A, Samet JH. LaBelle CT, et al. J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26. J Subst Abuse Treat. 2016. PMID: 26233698 Free PMC article.

4

Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.

Wang EA, Moore BA, Sullivan LE, Fiellin DA. Wang EA, et al. J Gen Intern Med. 2010 Jul;25(7):670-4. doi: 10.1007/s11606-010-1306-0. Epub 2010 Mar 6. J Gen Intern Med. 2010. PMID: 20213205 Free PMC article. Clinical Trial.

5

Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.

Carey KJ, Huang W, Linas BP, Tsui JI. Carey KJ, et al. J Subst Abuse Treat. 2016 Jul;66:54-9. doi: 10.1016/j.jsat.2016.01.009. Epub 2016 Feb 13. J Subst Abuse Treat. 2016. PMID: 26988423 Free PMC article.

6

Long-term retention in Office Based Opioid Treatment with buprenorphine.

Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Weinstein ZM, et al. J Subst Abuse Treat. 2017 Mar;74:65-70. doi: 10.1016/j.jsat.2016.12.010. Epub 2016 Dec 30. J Subst Abuse Treat. 2017. PMID: 28132702 Free PMC article.

7

Home- versus office-based buprenorphine inductions for opioid-dependent patients.

Sohler NL, Li X, Kunins HV, Sacajiu G, Giovanniello A, Whitley S, Cunningham CO. Sohler NL, et al. J Subst Abuse Treat. 2010 Mar;38(2):153-9. doi: 10.1016/j.jsat.2009.08.001. Epub 2009 Oct 3. J Subst Abuse Treat. 2010. PMID: 19801178 Free PMC article.

8

Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS. Moore BA, et al. J Gen Intern Med. 2007 Apr;22(4):527-30. doi: 10.1007/s11606-007-0129-0. J Gen Intern Med. 2007. PMID: 17372805 Free PMC article.

9

Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Rosenblatt RA, Andrilla CH, Catlin M, Larson EH. Rosenblatt RA, et al. Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735. Ann Fam Med. 2015. PMID: 25583888 Free PMC article.

10

Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.

Suzuki J, Zinser J, Klaiber B, Hannon M, Grassi H, Spinosa M, Ramirez A, Issa M, Chin Feman SP. Suzuki J, et al. Subst Abus. 2015;36(2):166-9. doi: 10.1080/08897077.2014.998400. Subst Abus. 2015. PMID: 25738320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed